Hypoxia in microscopic tumors

Cancer Letters

Volumn 264, Issue 2, 2008, Pages 172-180

  Li, Xiao Feng ^a   O'Donoghue, Joseph A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Angiogenesis; Hypoxia; Hypoxic resistance; Micrometastases; Microscopic tumors

Indexed keywords

1 (1,1,1,3,3,3 HEXAFLUORO 2 PROPOXY) 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 2 (2 NITRO 1H IMIDAZOL 1 YL) N (2,2,3,3,3 PENTAFLUOROPROPYL)ACETAMIDE; 2 NITROIMIDAZOLE; ANTINEOPLASTIC AGENT; IODO AZOMYCINGALACTOPYRANOSIDE; OXYGEN; PIMONIDAZOLE; TUMOR MARKER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CELL HYPOXIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOXIA; METASTASIS POTENTIAL; MICROSCOPIC ANATOMY; MOUSE; NONHUMAN; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; SOLID TUMOR;

ANIMALIA;

EID: 42749091227     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2008.02.037     Document Type: Review

References (71)

1. C.A. Huff W. Matsui B.D. Smith R.J. Jones The paradox of response and survival in cancer therapeutics Blood 107 2006 431 434
2. J.D. van der Bilt M.E. Soeters A.M. Duyverman M.W. Nijkamp P.O. Witteveen P.J. van Diest O. Kranenburg I.H. Borel Rinkes Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases Am. J. Pathol. 170 2007 1379 1388
3. R.J. Epstein Maintenance therapy to suppress micrometastasis: the new challenge for adjuvant cancer treatment Clin. Cancer Res. 11 2005 5337 5341
4. J. Folkman R. Kalluri Cancer without disease Nature 427 2004 787
5. G.N. Naumov L.A. Akslen J. Folkman Role of angiogenesis in human tumor dormancy: animal models of the angiogenic switch Cell Cycle 5 2006 1779 1787
6. 2 tension measurements Cancer Res. 51 1991 3316 3322
7. D.M. Brizel G.S. Sibley L.R. Prosnitz R.L. Scher M.W. Dewhirst Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck Int. J. Radiat. Oncol. Biol. Phys. 38 1997 285 289
8. L. Goethals A. Debucquoy C. Perneel K. Geboes N. Ectors H. De Schutter F. Penninckx W.H. McBride A.C. Begg K.M. Haustermans Hypoxia in human colorectal adenocarcinoma: comparison between extrinsic and potential intrinsic hypoxia markers Int. J. Radiat. Oncol. Biol. Phys. 65 2006 246 254
9. M. Nordsmark M. Overgaard J. Overgaard Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck Radiother. Oncol. 41 1996 31 39
10. B.G. Wouters S.A. Weppler M. Koritzinsky W. Landuyt S. Nuyts J. Theys R.K. Chiu P. Lambin Hypoxia as a target for combined modality treatments Eur. J. Cancer 38 2002 240 257
11. X.F. Li S. Carlin M. Urano J. Russell C.C. Ling J.A. O’Donoghue Visualization of hypoxia in microscopic tumors by immunofluorescent microscopy Cancer Res. 67 2007 7646 7653
12. X.F. Li P. Zanzonico C.C. Ling J. O’Donoghue Visualization of experimental lung and bone metastases in live nude mice by X-ray micro-computed tomography Technol. Cancer Res. Treat. 5 2006 147 155
13. M.D. Cameron E.E. Schmidt N. Kerkvliet K.V. Nadkarni V.L. Morris A.C. Groom A.F. Chambers I.C. MacDonald Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency Cancer Res. 60 2000 2541 2546
14. Y. Maniwa M. Okada N. Ishii K. Kiyooka Vascular endothelial growth factor increased by pulmonary surgery accelerates the growth of micrometastases in metastatic lung cancer Chest 114 1998 1668 1675
15. T. Hiraga S. Kizaka-Kondoh K. Hirota M. Hiraoka T. Yoneda Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer Cancer Res. 67 2007 4157 4163
16. X.F. Li S. Kinuya K. Yokoyama K. Koshida H. Mori K. Shiba N. Watanabe N. Shuke T. Michigishi N. Tonami Benefits of combined radioimmunotherapy and anti-angiogenic therapy in a liver metastasis model of human colon cancer cells Eur. J. Nucl. Med. Mol. Imaging 29 2002 1669 1674
17. S. Kinuya X.F. Li K. Yokoyama H. Mori K. Shiba N. Watanabe N. Shuke H. Bunko T. Michigishi N. Tonami Intraperitoneal radioimmunotherapy in treating peritoneal carcinomatosis of colon cancer in mice compared with systemic radioimmunotherapy Cancer Sci. 94 2003 650 654
18. S. Kinuya X.F. Li K. Yokoyama H. Mori K. Shiba N. Watanabe N. Shuke H. Bunko T. Michigishi N. Tonami Local delivery of (131)I-MIBG to treat peritoneal neuroblastoma Eur. J. Nucl. Med. Mol. Imaging 30 2003 1246 1250
19. N. Almog V. Henke L. Flores L. Hlatky A.L. Kung R.D. Wright R. Berger L. Hutchinson G.N. Naumov E. Bender L.A. Akslen E.G. Achilles J. Folkman Prolonged dormancy of human liposarcoma is associated with impaired tumor angiogenesis FASEB J. 20 2006 947 949
20. G.N. Naumov E. Bender D. Zurakowski S.Y. Kang D. Sampson E. Flynn R.S. Watnick O. Straume L.A. Akslen J. Folkman N. Almog A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype J. Natl. Cancer Inst. 98 2006 316 325
21. T. Udagawa A. Fernandez E.G. Achilles J. Folkman R.J. D’Amato Persistence of microscopic human cancers in mice: alterations in the angiogenic balance accompanies loss of tumor dormancy FASEB J. 16 2002 1361 1370
22. Y. Cao C.Y. Li B.J. Moeller D. Yu Y. Zhao M.R. Dreher S. Shan M.W. Dewhirst Observation of incipient tumor angiogenesis that is independent of hypoxia and hypoxia inducible factor-1 activation Cancer Res. 65 2005 5498 5505
23. A.S. Ljungkvist J. Bussink J.H. Kaanders A.J. van der Kogel Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers Radiat. Res. 167 2007 127 145
24. J.A. Raleigh S.C. Chou G.E. Arteel M.R. Horsman Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors Radiat. Res. 151 1999 580 589
25. J.H. Kaanders K.I. Wijffels H.A. Marres A.S. Ljungkvist L.A. Pop F.J. van den Hoogen P.C. de Wilde J. Bussink J.A. Raleigh A.J. van der Kogel Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer Cancer Res. 62 2002 7066 7074
26. J.A. Raleigh D.P. Calkins-Adams L.H. Rinker C.A. Ballenger M.C. Weissler W.C. Fowler Jr. D.B. Novotny M.A. Varia Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker Cancer Res. 58 1998 3765 3768
27. A.S. Ljungkvist J. Bussink P.F. Rijken J.A. Raleigh J. Denekamp A.J. Van Der Kogel Changes in tumor hypoxia measured with a double hypoxic marker technique Int. J. Radiat. Oncol. Biol. Phys. 48 2000 1529 1538
28. 2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models Int. J. Radiat. Oncol. Biol. Phys. 61 2005 1493 1502
29. 2 electrode measurements. Influence of tumour volume and carbogen breathing Acta Oncol. 41 2002 304 312
30. L. Dubois W. Landuyt K. Haustermans P. Dupont G. Bormans P. Vermaelen P. Flamen E. Verbeken L. Mortelmans Evaluation of hypoxia in an experimental rat tumour model by [(18)F]fluoromisonidazole PET and immunohistochemistry Br. J. Cancer 91 2004 1947 1954
31. P. Zanzonico J. O’Donoghue J.D. Chapman R. Schneider S. Cai S. Larson B. Wen Y. Chen R. Finn S. Ruan L. Gerweck J. Humm C. Ling Iodine-124-labeled iodo-azomycin-galactoside imaging of tumor hypoxia in mice with serial microPET scanning Eur. J. Nucl. Med. Mol. Imaging 31 2004 117 128
32. A. Pugachev S. Ruan S. Carlin S.M. Larson J. Campa C.C. Ling J.L. Humm Dependence of FDG uptake on tumor microenvironment Int. J. Radiat. Oncol. Biol. Phys. 62 2005 545 553
33. A.L. Harris Hypoxia – a key regulatory factor in tumour growth Nat. Rev. Cancer 2 2002 38 47
34. A. Driessen W. Landuyt S. Pastorekova J. Moons L. Goethals K. Haustermans P. Nafteux F. Penninckx K. Geboes T. Lerut N. Ectors Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas Ann. Surg. 243 2006 334 340
35. C.P. Potter A.L. Harris Diagnostic, prognostic and therapeutic implications of carbonic anhydrases in cancer Br. J. Cancer 89 2003 2 7
36. P.J. Hoskin A. Sibtain F.M. Daley G.D. Wilson GLUT1 and CAIX as intrinsic markers of hypoxia in bladder cancer: relationship with vascularity and proliferation as predictors of outcome of ARCON Br. J. Cancer 89 2003 1290 1297
37. M.I. Koukourakis A. Giatromanolaki E. Sivridis K. Simopoulos J. Pastorek C.C. Wykoff K.C. Gatter A.L. Harris Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy Clin. Cancer Res. 7 2001 3399 3403
38. R.E. Airley J. Loncaster J.A. Raleigh A.L. Harris S.E. Davidson R.D. Hunter C.M. West I.J. Stratford GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: relationship to pimonidazole binding Int. J. Cancer 104 2003 85 91
39. R.E. Airley A. Mobasheri Hypoxic regulation of glucose transport, anaerobic metabolism and angiogenesis in cancer: novel pathways and targets for anticancer therapeutics Chemotherapy 53 2007 233 256
40. R.J. Oliver R.T. Woodwards P. Sloan N.S. Thakker I.J. Stratford R.E. Airley Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Translational Research Fund studies Eur. J. Cancer 40 2004 503 507
41. E. Berra D. Roux D.E. Richard J. Pouyssegur Hypoxia-inducible factor-1 alpha (HIF-1 alpha) escapes O(2)-driven proteasomal degradation irrespective of its subcellular localization: nucleus or cytoplasm EMBO Rep. 2 2001 615 620
42. U.R. Jewell I. Kvietikova A. Scheid C. Bauer R.H. Wenger M. Gassmann Induction of HIF-1alpha in response to hypoxia is instantaneous FASEB J. 15 2001 1312 1314
43. K.J. Turner J.P. Crew C.C. Wykoff P.H. Watson R. Poulsom J. Pastorek P.J. Ratcliffe D. Cranston A.L. Harris The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial vs invasive bladder cancer Br. J. Cancer 86 2002 1276 1282
44. D. Vordermark A. Kaffer S. Riedl A. Katzer M. Flentje Characterization of carbonic anhydrase IX (CA IX) as an endogenous marker of chronic hypoxia in live human tumor cells Int. J. Radiat. Oncol. Biol. Phys. 61 2005 1197 1207
45. P.L. Olive C. Aquino-Parsons Measurement of tumor hypoxia using single-cell methods Semin. Radiat. Oncol. 14 2004 241 248
46. 2 Acta Oncol. 36 1997 183 189
47. D. Zhao A. Constantinescu E.W. Hahn R.P. Mason Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor Radiat. Res. 156 2001 510 520
48. K. De Jaeger F.M. Merlo M.C. Kavanagh A.W. Fyles D. Hedley R.P. Hill Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis Int. J. Radiat. Oncol. Biol. Phys. 42 1998 717 721
49. 2 using the OxyLite system in R3327-AT tumors under isoflurane anesthesia Radiat. Res. 166 2006 512 518
50. M. Urano Y. Chen J. Humm J.A. Koutcher P. Zanzonico C. Ling Measurements of tumor tissue oxygen tension using a time-resolved luminescence-based optical oxylite probe: comparison with a paired survival assay Radiat. Res. 158 2002 167 173
51. R.L. Barnhill M.W. Piepkorn A.J. Cochran E. Flynn T. Karaoli J. Folkman Tumor vascularity, proliferation, and apoptosis in human melanoma micrometastases and macrometastases Arch. Dermatol. 134 1998 991 994
52. J.A. Aguirre-Ghiso Models, mechanisms and clinical evidence for cancer dormancy Nat. Rev. Cancer 7 2007 834 846
53. J.A. Aguirre Ghiso K. Kovalski L. Ossowski Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling J. Cell Biol. 147 1999 89 104
54. J.A. Aguirre-Ghiso Y. Estrada D. Liu L. Ossowski ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK) Cancer Res. 63 2003 1684 1695
55. J.A. Aguirre-Ghiso D. Liu A. Mignatti K. Kovalski L. Ossowski Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo Mol. Biol. Cell 12 2001 863 879
56. R.E. Durand J.A. Raleigh Identification of nonproliferating but viable hypoxic tumor cells in vivo Cancer Res. 58 1998 3547 3550
57. A.S. Kennedy J.A. Raleigh G.M. Perez D.P. Calkins D.E. Thrall D.B. Novotny M.A. Varia Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays Int. J. Radiat. Oncol. Biol. Phys. 37 1997 897 905
58. C.W. Pugh P.J. Ratcliffe Regulation of angiogenesis by hypoxia: role of the HIF system Nat. Med. 9 2003 677 684
59. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62
60. M.M. Hickey M.C. Simon Regulation of angiogenesis by hypoxia and hypoxia-inducible factors Curr. Top. Dev. Biol. 76 2006 217 257
61. D. Liao R.S. Johnson Hypoxia: a key regulator of angiogenesis in cancer Cancer Metastasis Rev. 26 2007 281 290
62. Y. Mizukami Y. Kohgo D.C. Chung Hypoxia inducible factor-1 independent pathways in tumor angiogenesis Clin. Cancer Res. 13 2007 5670 5674
63. G.L. Semenza Targeting HIF-1 for cancer therapy Nat. Rev. Cancer 3 2003 721 732
64. A.C. Clavo R.S. Brown R.L. Wahl Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia J. Nucl. Med. 36 1995 1625 1632
65. A.C. Clavo R.L. Wahl Effects of hypoxia on the uptake of tritiated thymidine, l -leucine, l -methionine and FDG in cultured cancer cells J. Nucl. Med. 37 1996 502 506
66. P. Burgman J.A. Odonoghue J.L. Humm C.C. Ling Hypoxia-induced increase in FDG uptake in MCF7 cells J. Nucl. Med. 42 2001 170 175
67. R.A. Cairns I. Papandreou P.D. Sutphin N.C. Denko Metabolic targeting of hypoxia and HIF1 in solid tumors can enhance cytotoxic chemotherapy Proc. Natl. Acad. Sci. USA 104 2007 9445 9450
68. A.L. Bacon A.L. Harris Hypoxia-inducible factors and hypoxic cell death in tumour physiology Ann. Med. 36 2004 530 539
69. A. Chrastina J. Zavada S. Parkkila S. Kaluz M. Kaluzova J. Rajcani J. Pastorek S. Pastorekova Biodistribution and pharmacokinetics of 125I-labeled monoclonal antibody M75 specific for carbonic anhydrase IX, an intrinsic marker of hypoxia, in nude mice xenografted with human colorectal carcinoma Int. J. Cancer 105 2003 873 881
70. E.G. Troost J. Bussink J.H. Kaanders J. van Eerd J.P. Peters P.F. Rijken O.C. Boerman A.J. van der Kogel Comparison of different methods of CAIX quantification in relation to hypoxia in three human head and neck tumor lines Radiother. Oncol. 76 2005 194 199
71. K.H. Shin J.A. Diaz-Gonzalez J. Russell Q. Chen P. Burgman X.F. Li C.C. Ling Detecting changes in tumor hypoxia with carbonic anhydrase IX and pimonidazole Cancer Biol. Ther. 6 2007 70 75